US 8637038
Methods for inhibiting allograft rejection
granted A61KA61K31/436A61K31/4545
Quick answer
US patent 8637038 (Methods for inhibiting allograft rejection) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/436, A61K31/4545, A61K31/506, A61K38/13